BioPharm International
October 15, 2001
14
10
by Ludwig Huber at Agilent Technologies GmbH and Rory Budihandojo To comply with 21 CFR Part 11, your networked systems require the same validation and qualification steps as those for a single computer. Shared servers and multiple access also add requirements that are unique to networks. Italicized words in this article are defined in the "The Glossaryy" on the last page of the online version.
October 15, 2001
14
10
by Robert J. Seely, Louis Munyakazi, and John Haury Regulatory approval and successful manufacturing depend on establishing meaningful and reasonable acceptance criteria for process validations and ongoing monitoring. Three methods are presented here to correct for the likely underestimation of process limits due to small samples.
October 15, 2001
Columns and Departments
14
10
by David G. Jensen Your best people will be targeted.
October 15, 2001
Product Development
14
10
by Steven Ford and William E. Tente Chimeric Therapies, Inc. Manufacturing processes for murine monoclonal antibodies (mMABs) used in therapeutic applications must address more safety concerns than those used for in vitro diagnostics. Adequate characterization helps ensure that the mMAb retains its functional integrity after more extensive processing.
October 15, 2001
Columns and Departments
14
10
by Jill Wechsler Terrorist attack may postpone health policy legislation but encourage antibioterrorism initiatives.